Get started
Author

Mengyu Zhao

Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
2019 · Li-Shuang Zhang, Jun-Hua Zhang, et al. · The American Journal of Chinese Medicine · 51
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial
2025 · Mingming Zhang, Shan Fu, et al. · JAMA Oncology · 35
PDF
Nrf2/STAT3-mediated activation of SLC6A3 underlies the neuroprotective effect of quercetin in ischemic stroke
2025 · Huabao Cai, Meng-Yu Zhao, et al. · Phytomedicine · 17
Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value
2024 · Hua-Bao Cai, Meng-Yu Zhao, et al. · Frontiers in Immunology · 12
PDF
Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell therapy versus chemotherapy
2022 · Ting-Ting Yang, Ye Meng, et al. · Frontiers in Immunology · 11
PDF
Pesticin-Like Effector VgrG3 cp Targeting Peptidoglycan Delivered by the Type VI Secretion System Contributes to Vibrio cholerae Interbacterial Competition
2023 · Ming Liu, Meng-Yu Zhao, et al. · Microbiology Spectrum · 9
Vasoprotective Effects of Hyperoside against Cerebral Ischemia/Reperfusion Injury in Rats: Activation of Large-Conductance Ca2+-Activated K+ Channels
2023 · Wen-Ming Hong, Yue-Wu Xie, et al. · Neural Plasticity · 8
PDF
Predictive value of pre-treatment circulating tumor DNA genomic landscape in patients with relapsed/refractory multiple myeloma undergoing anti-BCMA CAR-T therapy: Insights from tumor cells and T cells
2024 · Rongrong Chen, Chunxiang Jin, et al. · Chinese Medical Journal · 7
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
2025 · Yetian Dong, Tingting Yang, et al. · Bone Marrow Transplantation · 6
PDF
Molecular insights into glioblastoma progression: role of CHCHD2P9 in tumor heterogeneity and prognosis
2025 · Yanyu Ding, Lizhi Xiao, et al. · Frontiers in Immunology · 6
Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment
2025 · Yangyang Cheng, Haoyang Yu, et al. · International Journal of Molecular Sciences · 6
Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial
2018 · Ying Tian, Junhua Zhang, et al. · Trials · 5
PDF
A Pathophysiology‐Informed, Negentropy‐Oriented Strategy for Nanomedicine in MASLD
2025 · Rui Mao, Meng Yu, et al. · Advanced Healthcare Materials · 4
Combining single-cell analysis and molecular docking techniques to construct a prognostic model for colon adenocarcinoma and uncovering inhibin subunit βb as a novel therapeutic target
2025 · Qinqing Wu, Lu Ye, et al. · Frontiers in Immunology · 4
The Higher Incidence of Liver Injury in HCC Patients Compared to Other Malignancies During Immune-Checkpoint Inhibitor Therapy is Primarily Due to Tumor Progression
2025 · Yan Wang, Liwei Liu, et al. · Therapeutics and Clinical Risk Management · 2
PDF
Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance
2025 · Meng-Yu Zhao, Zhao-Lei Shen, et al. · Frontiers in Immunology · 2
APRIL CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Phase I Clinical Trial
2024 · Wenxiao Li, Yongxian Hu, et al. · Blood · 1
Quercetin Alleviates Cerebral Ischemia/Reperfusion Injury by Regulating Tnf-1a/Hif-1α Activation of Vegfa/Vegfr/Akt/Pi3k Pathway
2024 · huabao CAI, Jialai Yang, et al. · SSRN Electronic Journal · 1
Synergistic Enhancement of Diosgenin Dissolution and Bioavailability via Ternary Solid Dispersions and Self-Assembled Polymeric Micelles
2026 · Jing-yi Li, Meng-yu Zhao, et al. · Drug Design Development and Therapy
Clinical manifestations, risk factors and prognosis associated with central nervous system relapse after CAR-T therapy for R/R B-cell non-Hodgkin lymphoma: A multi-center analysis
2025 · Tianning Gu, Tingting Yang, et al. · Blood
PDF
RETRACTED ARTICLE: Methylation-induced suppression of BEX1 activates AKT/ERK/STAT3 signaling pathways regulating cell cycle and apoptosis in glioma
2025 · Li-Zhi Xiao, Shi Feng, et al. · Scientific Reports
PDF
Characteristics of Central Nervous System Relapse after CD19 CAR-T Cell Therapy in R/R NHL
2023 · Mengyu Zhao, Tingting Yang, et al. · Blood
Works count: 22
Citation count: 187
H-index: 7
I10-index: 5
Year
Topic
Type